NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.210
-0.140 (-5.96%)
At close: Dec 10, 2025, 4:00 PM EST
2.230
+0.020 (0.90%)
After-hours: Dec 10, 2025, 5:58 PM EST
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $62.1 million as of December 10, 2025. Its market cap has increased by 316.75% in one year.
Market Cap
62.10M
Enterprise Value
64.89M
1-Year Change
316.75%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has decreased from $65.80M to $62.10M, a decrease of -5.63%. That is a compound annual growth rate of -0.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 66.00M | 148.12% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
| Nov 20, 2017 | 65.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 879.46B |
| Johnson & Johnson | 481.76B |
| AbbVie | 394.11B |
| UnitedHealth Group | 293.13B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 240.48B |
| Thermo Fisher Scientific | 211.55B |